{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:21Z","timestamp":1787002881536,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41375-025-02789-y","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:59:38Z","timestamp":1761559178000},"page":"215-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0292-2386","authenticated-orcid":false,"given":"Atte","family":"Nikkil\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-0797","authenticated-orcid":false,"given":"Olli","family":"Lohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laimonas","family":"Griskevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Hallb\u00f6\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3lafur G\u00edsli","family":"J\u00f3nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bendik","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-6522","authenticated-orcid":false,"given":"Hanne Vibeke","family":"Marquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Palk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaie","family":"Pruunsild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Quist-Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goda Elizabeta","family":"Vaitkeviciene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2803-2712","authenticated-orcid":false,"given":"Ulla","family":"Wartiovaara-Kautto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7637-1949","authenticated-orcid":false,"given":"Mats","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-0135","authenticated-orcid":false,"given":"Kim","family":"Vettenranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-4993","authenticated-orcid":false,"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2789_CR1","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1097\/HS9.0000000000000883","volume":"7","author":"U Nor\u00e9n-Nystr\u00f6m","year":"2023","unstructured":"Nor\u00e9n-Nystr\u00f6m U, Andersen MK, Barbany G, Dirse V, Eilert-Olsen M, Engvall M, et al. Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial. Hemasphere. 2023;7:e883.","journal-title":"Hemasphere"},{"key":"2789_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","volume":"32","author":"N Toft","year":"2018","unstructured":"Toft N, Birgens H, Abrahamsson J, Gri\u0161kevi\u010dius L, Hallb\u00f6\u00f6k H, Heyman M, et al. Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia. Leukemia. 2018;32:606\u201315.","journal-title":"Leukemia"},{"key":"2789_CR3","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1182\/blood-2013-10-532598","volume":"123","author":"V Conter","year":"2014","unstructured":"Conter V, Valsecchi MG, Parasole R, Putti MC, Locatelli F, Barisone E, et al. Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. Blood. 2014;123:1470\u20138.","journal-title":"Blood"},{"key":"2789_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/leu.2009.251","volume":"24","author":"K Schmiegelow","year":"2010","unstructured":"Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, S\u00f6derh\u00e4ll S, et al. Nordic Society of Paediatric Haematology and Oncology. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia. 2010;24:345\u201354.","journal-title":"Leukemia"},{"key":"2789_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S1470-2045(14)70243-8","volume":"15","author":"A Vora","year":"2014","unstructured":"Vora A, Goulden N, Mitchell C, Hancock J, Hough R, Rowntree C, et al. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2014;15:809\u201318.","journal-title":"Lancet Oncol"},{"key":"2789_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pbc.10461","volume":"42","author":"UM Saarinen-Pihkala","year":"2004","unstructured":"Saarinen-Pihkala UM, Gustafsson G, Carlsen N, Flaegstad T, Forestier E, Glomstein A, et al. Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation. Pediatr Blood Cancer. 2004;42:8\u201323.","journal-title":"Pediatr Blood Cancer"},{"key":"2789_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MPH.0b013e3182352da9","volume":"34","author":"UM Saarinen-Pihkala","year":"2012","unstructured":"Saarinen-Pihkala UM, Parto K, Riikonen P, L\u00e4hteenm\u00e4ki PM, B\u00e9k\u00e0ssy AN, Glomstein A, et al. RALLE pilot: response-guided therapy for marrow relapse in acute lymphoblastic leukemia in children. J Pediatr Hematol Oncol. 2012;34:263\u201370.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2789_CR8","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/bjh.15761","volume":"184","author":"M Ifversen","year":"2019","unstructured":"Ifversen M, Turkiewicz D, Marquart HV, Winiarski J, Buechner J, Mellgren K, et al. Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience. Br J Haematol. 2019;184:982\u201393.","journal-title":"Br J Haematol"},{"key":"2789_CR9","doi-asserted-by":"publisher","first-page":"S222","DOI":"10.3816\/CLM.2009.s.016","volume":"9","author":"D Bhojwani","year":"2009","unstructured":"Bhojwani D, Howard SC, Pui CH. High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma. 2009;9:S222\u2013S230.","journal-title":"Clin Lymphoma Myeloma"},{"key":"2789_CR10","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children\u2019s Oncology Group. J Clin Oncol. 2012;30:1663\u20139.","journal-title":"J Clin Oncol"},{"key":"2789_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1200\/JCO.18.00884","volume":"37","author":"JL McNeer","year":"2019","unstructured":"McNeer JL, Devidas M, Dai Y, Carroll AJ, Heerema NA, Gastier-Foster JM, et al. Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children\u2019s Oncology Group. J Clin Oncol. 2019;37:780\u20139.","journal-title":"J Clin Oncol"},{"key":"2789_CR12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/leu.2013.44","volume":"27","author":"GM Marshall","year":"2013","unstructured":"Marshall GM, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman HA, van der Velden VH, et al. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia. 2013;27:1497\u2013503.","journal-title":"Leukemia"},{"key":"2789_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1200\/JCO.18.00822","volume":"37","author":"CH Pui","year":"2019","unstructured":"Pui CH, Rebora P, Schrappe M, Attarbaschi A, Baruchel A, Basso G, et al. Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study. J Clin Oncol. 2019;37:770\u20139.","journal-title":"J Clin Oncol"},{"key":"2789_CR14","doi-asserted-by":"crossref","unstructured":"van Binsbergen AL, de Haas V, van der Velden VHJ, de Groot-Kruseman HA, Fiocco MF, Pieters R. Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2022;69:e29387.","DOI":"10.1002\/pbc.29387"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02789-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02789-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02789-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:03:33Z","timestamp":1767985413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02789-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2789"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02789-y","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The NOPHO ALL2008 study (EudraCT 2008-003235-20) was approved by the regional research ethics committee of the Capital Region of Denmark (Protocol No. H-2-2010-002), the Danish Data Protection Agency (Journal No. 2012-58-0004), and by the scientific ethical review boards of all involved countries. All patients gave written informed consent, and the study was conducted in accordance with the Declaration of Helsinki (version 2008).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}